Whole Genome Sequencing
9
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited Cardiomyopathy
N-Care Project: Enhancing Asian-Pacific Collaboration
Ultra Rapid GEnome Sequencing
South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South
Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform
A Study of Consent Forms for Whole Exome and Whole Genome Sequencing
WGS of NTM From Sputum of NTM Lung Disease Patients and From Their Environments